Clinical Trial Update: Trial of Miltefosine in Cutaneous Leishmaniasis (Brazil) [Phase 2]

View source ↗

Summary

This is an update on a Phase 2 trial of miltefosine for cutaneous leishmaniasis in Brazil. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Miltefosine (miltefosine)

Snippet

Sponsor: Hospital Universitário Professor Edgard Santos | Conditions: Treatment of Cutaneous Leishmaniasis in Brazil. | Phase 2 | Status: COMPLETED